Vimarsana
Biggest News Aggregation in the World

Xpert Mpox News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xpert Mpox. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xpert Mpox Today - Breaking & Trending Today

India Emerging Infectious Disease Diagnostics Market Poised to Reach $982.7 Million by 2033, Fueled by Advancements in Diagnostic Technologies and Demand for Rapid Testing - Vimarsana News

India Emerging Infectious Disease Diagnostics Market Poised to Reach $982.7 Million by 2033, Fueled by Advancements in Diagnostic Technologies and Demand for Rapid Testing

/PRNewswire/ -- The "India Emerging Infectious Disease Diagnostics Market: Focus on Epidemiology, Application, Technology, Type of Infection, Disease Type, and...

Key Players in India's Emerging Infectious Disease - Vimarsana News

Key Players in India's Emerging Infectious Disease

Dublin, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The

Cepheid Receives Emergency Use Authorization from FDA for Xpert® Mpox - Vimarsana News

Cepheid Receives Emergency Use Authorization from FDA for Xpert® Mpox

/PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration for Xpert Mpox, which runs...

FDA authorizes Cepheid molecular test to detect monkeypox virus at the point of care - Vimarsana News

FDA authorizes Cepheid molecular test to detect monkeypox virus at the point of care

The Xpert Mpox test is a real-time polymerase chain reaction assay to detect Mpox virus DNA in lesion swab specimens from individuals suspected of monkeypox by their healthcare provider.

FDA Roundup: February 10, 2023 - Vimarsana News

FDA Roundup: February 10, 2023

/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued an...